Developmental toxicity of bisphenol A and immune-mediated diseases
双酚A的发育毒性和免疫介导的疾病
基本信息
- 批准号:7852485
- 负责人:
- 金额:$ 58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-28 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffectAmericanAnimal ModelAreaAsthmaBasic ScienceBiologicalBiological AssayBiological ModelsBone MarrowBone Marrow Cell TransplantationCell LineageCell physiologyCellsChemicalsChimera organismChronicClinical ImmunologyCommitComputer Systems DevelopmentDataDevelopmentDiseaseDisease OutcomeDisease susceptibilityDoseExposure toGastrointestinal DiseasesGrantHealthHematopoiesisHematopoietic stem cellsHumanHuman DevelopmentImmuneImmune systemImmunobiologyImmunologyInfectionInflammatoryInflammatory Bowel DiseasesInfluenzaInfluenza A virusKnowledgeLaboratoriesLeadLearningLifeLinkLungMaternal ExposureMeasuresMediatingMolecular GeneticsMolecular TargetMucosal ImmunityMusOccupationsOrganPredispositionReagentRecoveryRegulatory PathwayRelative (related person)ReportingResearchResearch DesignResearch Project GrantsResolutionRespiratory Tract InfectionsScientistTestingThymus GlandToxic effectToxicologyUncertaintyWorkbasebisphenol Acellular targetingdesigngene environment interactionhuman diseaseimmunotoxicityimprovedinterestmouse modelpollutantpreventprimary outcomepublic health relevancereceptorresearch studysecondary outcometranscription factor
项目摘要
DESCRIPTION (provided by applicant): The objective of this project is to provide the most detailed analysis to-date of the impact of the chemical bisphenol A (BPA) on immune system development, and will specifically test the hypothesis that developmental BPA exposure enhances susceptibility to three common immune-mediated diseases later in life. The proposed research is a large-scale project that will improve synergy and interactions among an integrated, multi-disciplinary research team with expertise in toxicology, immunology, immune development, and pulmonary and gastrointestinal diseases. In the 1st Aim a determination of how developmental exposure to BPA affects the development of the immune system will be investigated. The 2nd Aim will use mouse models of asthma, inflammatory bowel disease and infection with influenza A virus to determine how developmental exposure to BPA affects the onset, activity, and resolution of these diseases. Further studies will then probe underlying changes in the function of cellular components of the innate and adaptive immune system, and in the 3rd Aim, an identification of the cellular targets of BPA that lead to increased disease susceptibility using a combination of modern immunological approaches such as bone marrow chimeras, adoptive transfer, and disease-specific functional assays will ensue. Evaluating how BPA impacts the developing immune system in the context animal models of common human diseases will deliver many benefits. First, BPA interacts with receptors that are transcription factors, but the contribution of these interactions to disease are not entirely clear; therefore what is learned will provide new information about how gene-environment interactions influence immune development and function. Second, developmental exposure to BPA likely contributes to other human diseases, and many of the regulatory pathways activated in the model systems we will use are deregulated in other diseases. Given the growing link between pollutants, respiratory infection, and chronic inflammatory diseases, these studies will help delineate the causal basis for these relationships, and may lead to the discovery of common molecular targets of BPA and new strategies to prevent or mitigate environmentally-mediated diseases. Finally, in addition to creating new scientific information, the proposed research will directly advance the objectives of the American Reinvestment and Recovery Act by enabling the hiring of new laboratory staff and the procurement of research reagents and supplies. Thus, this project will have direct, positive impact on the local and national economy.
PUBLIC HEALTH RELEVANCE: This research addresses growing concern about how bisphenol A impacts development and contributes to human disease, and will improve our understanding of the potential for bisphenol A to affect the developing immune system and lead to poorer health later in life.
描述(由申请人提供):该项目的目的是提供迄今为止最详细的分析化学双酚A(BPA)对免疫系统发育的影响,并将专门测试发育BPA暴露增强对三种常见免疫介导疾病的易感性的假设。拟议的研究是一个大规模的项目,将改善一个综合的多学科研究团队之间的协同作用和互动,该团队具有毒理学,免疫学,免疫发育以及肺和胃肠道疾病方面的专业知识。在第一个目标中,将研究BPA发育暴露如何影响免疫系统的发育。第二个目标将使用哮喘,炎症性肠病和甲型流感病毒感染的小鼠模型来确定BPA的发育暴露如何影响这些疾病的发作,活动和解决。进一步的研究将探索先天性和适应性免疫系统细胞成分功能的潜在变化,在第三个目标中,将使用现代免疫学方法(如骨髓嵌合体、过继转移和疾病特异性功能测定)的组合来鉴定导致疾病易感性增加的BPA细胞靶点。在人类常见疾病的动物模型中评估BPA如何影响发育中的免疫系统将带来许多好处。首先,BPA与转录因子受体相互作用,但这些相互作用对疾病的贡献尚不完全清楚;因此,所了解的将提供有关基因-环境相互作用如何影响免疫发育和功能的新信息。第二,BPA的发育暴露可能会导致其他人类疾病,我们将使用的模型系统中激活的许多调节途径在其他疾病中被解除管制。鉴于污染物、呼吸道感染和慢性炎症性疾病之间的联系日益密切,这些研究将有助于阐明这些关系的因果基础,并可能导致发现BPA的共同分子靶点和预防或减轻环境介导的疾病的新策略。最后,除了创造新的科学信息外,拟议的研究还将通过雇用新的实验室工作人员和采购研究试剂和用品,直接推进《美国再投资和复苏法》的目标。因此,该项目将对当地和国家经济产生直接的积极影响。
公共卫生相关性:这项研究解决了人们对双酚A如何影响发育和导致人类疾病的日益关注,并将提高我们对双酚A影响发育中的免疫系统并导致晚年健康状况恶化的潜力的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
B Paige Lawrence其他文献
B Paige Lawrence的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('B Paige Lawrence', 18)}}的其他基金
Environmental Agents as Modulators of Disease Processes
环境因素作为疾病过程的调节剂
- 批准号:
10852393 - 财政年份:2023
- 资助金额:
$ 58万 - 项目类别:
AHR 2016: The aryl hydrocarbon receptor as a central mediator of health and disease
AHR 2016:芳烃受体作为健康和疾病的中心介质
- 批准号:
9121735 - 财政年份:2016
- 资助金额:
$ 58万 - 项目类别:
Transgenerational exposures as modifiers of host defense against infection
跨代暴露作为宿主防御感染的调节剂
- 批准号:
8901170 - 财政年份:2013
- 资助金额:
$ 58万 - 项目类别:
Transgenerational exposures as modifiers of host defense against infection
跨代暴露作为宿主防御感染的调节剂
- 批准号:
8596955 - 财政年份:2013
- 资助金额:
$ 58万 - 项目类别:
Transgenerational exposures as modifiers of host defense against infection
跨代暴露作为宿主防御感染的调节剂
- 批准号:
8728235 - 财政年份:2013
- 资助金额:
$ 58万 - 项目类别:
Transgenerational exposures as modifiers of host defense against infection
跨代暴露作为宿主防御感染的调节剂
- 批准号:
9116844 - 财政年份:2013
- 资助金额:
$ 58万 - 项目类别:
Transgenerational exposures as modifiers of host defense against infection
跨代暴露作为宿主防御感染的调节剂
- 批准号:
9322005 - 财政年份:2013
- 资助金额:
$ 58万 - 项目类别:
Environmental Influences on Epigenetic Immune Programming
环境对表观遗传免疫编程的影响
- 批准号:
8204752 - 财政年份:2010
- 资助金额:
$ 58万 - 项目类别:
Environmental Influences on Epigenetic Immune Programming
环境对表观遗传免疫编程的影响
- 批准号:
8391744 - 财政年份:2010
- 资助金额:
$ 58万 - 项目类别:
Environmental Influences on Epigenetic Immune Programming
环境对表观遗传免疫编程的影响
- 批准号:
8267796 - 财政年份:2010
- 资助金额:
$ 58万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 58万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 58万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 58万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 58万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 58万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 58万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 58万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 58万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 58万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 58万 - 项目类别:














{{item.name}}会员




